J&J
ActiveOverview
Johnson & Johnson (J&J) is an American multinational corporation focused on pharmaceuticals, biotechnology, and medical technologies, operating through Innovative Medicine and MedTech segments.124 Following the 2023 spin-off of its consumer health business to Kenvue, the company concentrates on high-growth areas including oncology, immunology, neuroscience, and cardiovascular technology, with a global workforce and substantial R&D investments.24
History
Johnson & Johnson was founded in 1886 by brothers Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, initially producing ready-to-use sterile surgical dressings.4 The company expanded into pharmaceuticals, medical devices, and consumer products, becoming a diversified healthcare giant operating in over 60 countries.3 In 2023, it spun off its consumer health business as Kenvue to focus on Innovative Medicine (formerly Janssen) and MedTech.2 By 2025, J&J reported nearly $89 billion in revenue amid ongoing acquisitions.4
Product Lines
| Product Line | Positioning | Price Range |
|---|---|---|
| Innovative Medicine Pharmaceuticals | Prescription drugs for oncology and immunology | $10,000 - $100,000+ annually |
| MedTech Surgical Devices | Advanced surgical equipment and robotics | $5,000 - $2,000,000 |
| Orthopedic Products | Joint replacement and monitoring devices | $1,500 - $50,000 |
| Vision Care (Contact Lenses) | Daily and specialty contact lenses | $20 - $150 monthly |
| Biologics and Cell Therapy | CAR-T and gene therapies for cancer | $300,000 - $500,000 per treatment |
Manufacturing
Johnson & Johnson operates 64 manufacturing facilities worldwide.1 Production covers pharmaceuticals, biologics, and medical devices, with a mix of in-house operations and global supply chains.12 Facilities support sterile dressings, drugs, and advanced robotics.4
Notable Products
- Darzalex - Monoclonal antibody for multiple myeloma treatment, a top-selling drug.
- Stelara - Biologic for psoriasis, Crohn's disease, and ulcerative colitis.
- Tremfya - Treatment for plaque psoriasis and psoriatic arthritis.
- Remicade - Biosimilar for autoimmune diseases like rheumatoid arthritis.
- Velcade - Proteasome inhibitor for blood cancers including multiple myeloma.
Reputation
Johnson & Johnson is regarded as a global leader in healthcare innovation, particularly in oncology and immunology, with strong rankings in Fortune's World's Most Admired Companies and Access to Medicine Index.5 Professionals value its robust R&D pipeline and first-in-class therapies.2 Criticisms include past product safety issues and legal challenges related to talc and opioids, though the company maintains a prime AAA credit rating.4